API CAS 245765-41-7 Ozenoxacin Antibiotics Ozenoxacin Intermediate Powder Ozenoxacin

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Ozenoxacin
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Ozenoxacin
• Name: Ozenoxacin Powder
• Appearance: off-White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Antibiotics
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 245765-41-7
• Mf: C21h21n3o3
• MW: 363.417
• Density: 1.372+-0.06 g/cm3(Predicted)
• Boiling Point: 573.5+-50.0 C(Predicted)
• Flash Point: 300.7+-30.1 C
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 500kg/Month

Product Description

API CAS 245765-41-7 Ozenoxacin Antibiotics Ozenoxacin Intermediate Powder Ozenoxacin

 

Product Description

Product Details

Product Name	Ozenoxacin
CAS No.	245765-41-7
MF	C21H21N3O3
MW	363.417
Appearance and shape	Off-white powder

Ozenoxacin is a new type of non-fluoroquinolone antibacterial drug for the treatment of pustular dermatitis and other skin infections.By inhibiting DNA gyrase and topoisomerase IV, it is used as a cream (10g , 1%) to treat bacterial skin infections, including Gram-positive skin and soft tissue infections. At present, the compound has successfully completed the Phase III clinical trials for the treatment of adult Chemicalbook and pustular dermatitis in children, showing stronger antibacterial activity, safety and tolerability.Ozefloxacin was launched in Japan in July 2014 and was approved in September 2015 for the treatment of acne and skin infections (10g, 2%, gel).Ozefloxacin has a long chemical synthesis route.In its synthesis process, the following compound is an important Ozefloxacin intermediate.

Application & Function

Ozenoxacin is an experimental quinolone antibiotic being developed for the treatment of impetigo and other dermatological bacterial infections.Ozenoxacin is active against some bacteria that have developed resistance to currently used quinolone and fluoroquinolone antibiotics.
Product Function
It is used to treat impetigo caused by Staphylococcus aureus or Streptococcus pyogenes in patients aged two months and over. Ozenoxacin is used to treat infections including: respiratory tract infections,cellulitis,urinary tract infections,prostatitis,anthrax,endocarditis,meningitis,pelvic inflammatory disease,traveler's diarrhea,tuberculosis andplague.

Specification